|
 |
|
|
Guidelines
Any planned research protocol to be conducted in the State of California in the following categories must first be submitted to the Research Advisory Panel of California for review and approval:
- a) any research involving any Schedule I controlled substance;
- b) human research utilizing any Schedule I or Schedule II controlled substance; or
- c) research for the treatment of drug abuse utilizing any drug, scheduled or not.
Applicants may check with the Panel or the federal Drug Enforcement Administration to determine if the planned study drugs are classified as Schedule I or Schedule II.
Researchers using Schedule II (in non-human research), III, IV or V controlled substances need not apply to the Research Advisory Panel; however, registration with the DEA is required.
The Panel meets bimonthly (January, March, May, July, September, and November) to consider new and amended research applications. To be eligible for consideration, research protocols must be received by the 25th day of the month preceding an official meeting and must conform with the Panel's application requirements.
Applications are confidential to the extent permitted by laws governing trade secrets and commercial, personal privacy and property rights.
Applicants are encouraged to contact the Panel's office for assistance in preparation of research applications.
|
|
